# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-25-118330
Filing Date
2025-05-13
Accepted
2025-05-13 08:00:27
Documents
19
Period of Report
2025-06-09

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | d876184ddef14a.htm iXBRL | DEF 14A | 557770
3 | GRAPHIC | g876184g01a02.jpg | GRAPHIC | 35074
4 | GRAPHIC | g876184g46l38.jpg | GRAPHIC | 155061
5 | GRAPHIC | g876184g48d49.jpg | GRAPHIC | 178346
6 | GRAPHIC | g876184g89a01.jpg | GRAPHIC | 348646
7 | GRAPHIC | g876184g89a02.jpg | GRAPHIC | 225355
| Complete submission text file | 0001193125-25-118330.txt |  | 3370716

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA | caba-20241231.xsd | EX-101.SCH | 2504
22 | EXTRACTED XBRL INSTANCE DOCUMENT | d876184ddef14a_htm.xml | XML | 103405

Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100
Cabaletta Bio, Inc. (Filer) CIK: 0001759138 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39103 | Film No.: 25937224
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)